Assessment of SOX2 expression as a tumor stem cell marker in Ameloblastoma and Dentigerous cyst
Mansoura Journal of Dentistry · 01.01.2025 · 12 (3)
DOI: 10.61793/2812-5479.1161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mansoura Journal of Dentistry, online erschienen am 01.01.2025. Verfasst von Haneen Mahmoud Zeen El-Abdeen und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
The pathogenesis of odontogenic lesions remains unclear; however, a probable explanation could mean the presence of tumor stem cells (TSCs). The preservation of stem cells during early dental development is governed by many transcription factors, including sex-determining region Y (SRY)-box 2 (SOX-2). Numerous studies observed the increased expression of SOX2 in various benign and malignant tumors as its impact on tumorigenesis varies according to tumor type. This research aims to determine the predictive importance of the SOX2 stem cell marker by evaluating its immunoexpression in ameloblastoma (Ab) and dentigerous cyst (DC). Materials and Methods: Twenty-Four samples were part of this investigation, 15 ameloblastomas (Ab) and 9 dentigerous cyst (DC). The SOX2 Polyclonal Antibody was used for immunohistochemical (IHC) staining, and SOX2 expression was assessed by two methods, computer-assisted digital image analysis and semi-quantitative method. Positive specimens were considered when nucleus had brown staining.
Results
All cases in the two groups showed positive SOX2 expression. SOX2 expression in (Ab) was stronger than (DC) as ameloblastoma showed nuclear and cytoblasmic reaction, while SOX2 immunoreactivity was low positive in dentigerous cyst cases. Significant difference found between ameloblastoma (Ab) and dentigerous cyst (DC).
Conclusion
SOX2 serves as a viable marker for recognizing the presence of tumor stem cells (TSCs) within odontogenic lesions which contribute in high recurrence rate of these lesions and can affect patient prognosis. Recognizing such factors is essential for improved treatment and outcome of odontogenic lesions to enhance therapeutic efficacy and avoid recurrence
Zitieren
APA
El-Abdeen, H. M. Z., Mansour, N. A., Elnagdy, S. Y., & Tawfik, M. A. (2025). Assessment of SOX2 expression as a tumor stem cell marker in Ameloblastoma and Dentigerous cyst. Mansoura Journal of Dentistry, 12(3). https://doi.org/10.61793/2812-5479.1161
Vancouver
El-Abdeen HMZ, Mansour NA, Elnagdy SY, Tawfik MA. Assessment of SOX2 expression as a tumor stem cell marker in Ameloblastoma and Dentigerous cyst. Mansoura Journal of Dentistry. 2025;12(3). doi:10.61793/2812-5479.1161
BibTeX
@article{ElAbdeen2025,
author = {El-Abdeen, Haneen Mahmoud Zeen and Mansour, Noha Ahmed and Elnagdy, Sherif Yousef and Tawfik, Mohamed Abdel-Monem},
title = {Assessment of SOX2 expression as a tumor stem cell marker in Ameloblastoma and Dentigerous cyst},
journal = {Mansoura Journal of Dentistry},
year = {2025},
volume = {12},
number = {3},
doi = {10.61793/2812-5479.1161}
}
EUVIMED